Special ingredients are proven to bind water to skin and help prevent moisture loss

* No medical claims are made or implied for any product and these are being sold as Nutritional/Dietary Supplements

Triforge 10/160/12

The use of MenaQ7®

Eczemus 0.3 % Ointment, 10g - Brookes Pharma Pack Size:10 g Special ingredients are proven toFor treatment of Eczema Eczemus (Tacrolimus) is a macrolide immunosuppressant produced by streptomyces tsukubaensis. It has been demonstrated that Eczemus (Tacrolimus) inhibits T lymphocyte activation by first binding to an intracellular protein,FKBP 12. Eczemus (Tacrolimus) has also been shown to inhibit the release of inflammatory mediators from skin mast cells, basophils and eosinophils. Eczemus (Tacrolimus) ointment does not affect collagen